Neovascular glaucoma
MONDO:0019783Neovascular glaucoma is the most common type of secondary glaucoma, usually caused by diabetic retinopathy, central retinal vein occlusion and carotid artery obstruction but sometimes by trauma, uvietis or ocular tumors, and characterized by severe eye pain, synechial angle glaucoma, high intraocular pressure and leading to loss of vision.
12 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Eylea eyed as treatment for glaucoma caused by abnormal blood vessels
Disease control Recruiting nowThis study is tracking 480 people with neovascular glaucoma, a serious eye condition, who are receiving the drug Eylea (aflibercept) as part of their normal care. Researchers are monitoring side effects and how well the drug controls eye pressure and vision over 6 months. The goa…
Sponsor: Bayer • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Glaucoma patients: could this supplement save your sight?
Disease control Recruiting nowThis study tests whether a daily supplement called BrudyGlauco (containing DHA and citicoline) can help protect eyesight in people with glaucoma. About 108 participants will take either the supplement or a placebo for 12 months. The goal is to see if it slows vision loss and impr…
Phase: NA • Sponsor: Institut Catala de Retina • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Eye scan may spot hidden blood-flow changes that signal glaucoma risk in diabetes
Knowledge-focused Recruiting nowThis observational study uses a painless, non-invasive eye scan called iris OCTA to measure blood flow in the iris of people with type 2 diabetes. Researchers want to see if blood-flow patterns differ between healthy eyes, diabetic eyes without complications, and those with diabe…
Sponsor: Qilu Hospital of Shandong University • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC